Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Former high school athlete agrees to defect to China on $100m sponsorship deal
    • Satire

    Former high school athlete agrees to defect to China on $100m sponsorship deal

    Fresh off the Winter Olympics triumph of Eileen Gu who shone a light on the possibilities of budding female athletes around China, fellow half-Asian Hu Honey has confirmed that he too will follow a similar path to represent China on the global sporting stage.  The decision to turn his back on Australia, his country of

    Read More
    Public
  • Harris Technology solving rapid antigen test shortages, now selling online
    • News

    Harris Technology solving rapid antigen test shortages, now selling online

    Tapping their network of international vendors, online retailer Harris Technology (ASX: HT8) have succeeded where pharmacies and supermarkets have failed, securing commercial quantities of rapid antigen test kits (RATs) that they have listed through their eCommerce channels at discount prices.  The RATs have been added to their Pro-Hygiene division which was established at the start

    Read More
    Public
  • Shareholders smashed with 95% loss as American BNPL operator Zebit rage quits from the ASX
    • News

    Shareholders smashed with 95% loss as American BNPL operator Zebit rage quits from the ASX

    At a time when the likes of Afterpay and ZipCo were booming, American buy-now-pay-later company Zebit (ASX: ZBT) thought they could quench Australian investors’ thirst for BNPL exposure when listing on the ASX in October 2020 via a $35 million IPO. But with mounting bad debts from its customers, Zebit has decided that it’s all

    Read More
    Public
  • Adherium has begun manufacturing of their FDA approved respiratory inhaler
    • News

    Adherium has begun manufacturing of their FDA approved respiratory inhaler

    5-10% of the world’s population suffer from asthma. That’s over 23 million people, 7 million of whom are children.  Whilst for some it is a minor nuisance, asthma can be a chronic and often debilitating problem and can be a precursor to numerous comorbidities. The condition causes the airways to narrow and potentially produce more

    Read More
    Public
  • Mighty Kingdom set to release Conan Chop Chop as first console game title
    • News

    Mighty Kingdom set to release Conan Chop Chop as first console game title

    Tackling the hugely competitive market for multiplayer online gaming, game developer Mighty Kingdom (ASX: MKL) is set to join the party with the first ever title for console to be Conan Chop Chop – an online hack’n’slash game for kids.  Development of Conan Chop Chop first commenced in March 2019 when Mighty Kingdom partnered with

    Read More
    Public
  • What caused Meta shares to plunge?
    • Opinion

    What caused Meta shares to plunge?

    Facebook, now Meta, is the company everybody loves to hate. With that in mind, it’s easy to see why the events last week brought such delight to many people. Meta’s market cap dropped by 26%, erasing USD $240 billion worth of value – this was the single most significant market cap drop in history for

    Read More
    Public
  • «
  • ‹
  • 410
  • 411
  • 412
  • 413
  • 414
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.